Publication | Closed Access
Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy
28
Citations
30
References
2016
Year
NLR is a more reliable marker than ESR or CRP for evaluating the disease activity in patients with RA during tocilizumab therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1